Synopsis of recent research by authors named "Aifang Yang"
- Aifang Yang's recent research focuses on the efficacy and safety of medical treatments, particularly examining dacomitinib for advanced non-small cell lung cancer (NSCLC) with uncommon EGFR mutations, as highlighted in a 2023 study published in BMC Cancer.
- The author has also explored the role of circulating microRNAs, specifically miR-155, miR-96, and miR-99a, as potential diagnostic and prognostic tools for hepatocellular carcinoma, indicating their significance in cancer management, as detailed in a 2019 article in Oncol Letters.
- Aifang Yang has conducted studies to assess medication adherence in various patient populations, including asthma and hypertension, utilizing validated questionnaires to understand beliefs and factors influencing adherence, demonstrating a commitment to improving patient outcomes in diverse medical contexts.